More batches of Moderna COVID-19 shots shipped amid reports of shortages
Sep 22, 2022
While supplies of the updated Pfizer booster shot appear to be plentiful, some pharmacies have reported not having enough Moderna vaccine.
US COVID-19 hospitalizations rise for fourth straight week
Aug 16, 2023
Cases occurring at nursing homes were also high. Severe COVID-19 recently seems to have been striking seniors ages 75 years and older most often.
Decision on J&J COVID-19 vaccine booster doses could take weeks
Aug 20, 2021
Federal health officials are waiting on results from a government-backed clinical trial and from studies by Johnson & Johnson
Biogen cuts price of controversial Aduhelm in half
Dec 21, 2021
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
FDA approves omicron-specific booster shots from Pfizer, Moderna
Aug 31, 2022
The vaccine advisory panel for the CDC is set to meet Thursday and Friday to discuss who should get the updated boosters.
Vaccine rollout linked to drop in severe COVID-19 in dialysis patients
Feb 28, 2022
And patients on maintenance dialysis who received COVID-19 vaccination had decreasing antibody titers over time.
Moderna says its combo vaccine effective against omicron
Apr 19, 2022
The company says the combination vaccine triggers antibodies capable of fighting several variants, including beta and omicron.
FDA advisers support new Alzheimer’s drug
Jun 11, 2024
A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...
Americans short on sleep, stressed out about it: poll
Apr 15, 2024
More than half of Americans say they would feel better with more sleep, but only 42% say they are getting as much shut-eye as they need, a new poll finds.